Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Daniel Lynch currently holds 12,216 shares of bluebird bio, Inc. (BLUE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel Lynch has been a net seller of BLUE stock. They have purchased $0 and sold $13.9M worth of shares.
Daniel Lynch's most recent insider trade was on Jul 1, 2025, when they sold 93,004 shares at $0.00 per share.
Daniel Lynch serves as Executive at bluebird bio, Inc. (BLUE). They have executed 116 insider transactions totaling $13.9M over their tenure at the company.
Daniel Lynch holds the position of Executive at bluebird bio, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Daniel Lynch has shown a selling trading pattern, with $0 in total purchases and $13.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Daniel Lynch was on Jun 28, 2017, when they sold $1.1M worth of BPMC shares. This transaction involved 21,474 shares at $50.12 per share.
Daniel Lynch currently owns 12,216 shares of bluebird bio, Inc. (BLUE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Daniel Lynch's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Daniel Lynch has 116 Form 4 filings on record as an insider at bluebird bio, Inc..
Set alerts for Daniel Lynch and 40,000+ other insiders.